Clinical Trial Update: Recombinant Human Keratinocyte Growth Factor in Unrelated and Related Transplants [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating recombinant human keratinocyte growth factor in unrelated and related transplants for graft-versus-host disease. The study h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Recombinant Human Keratinocyte Growth Factor (keratinocyte growth factor-1)

Snippet

Sponsor: University of Michigan | Conditions: Graft Versus Host Disease | Phase 1, Phase 2 | Status: COMPLETED